Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. However, infants, older adults and those with certain risk factors are more likely to develop severe RSV illness and need hospitalization. Despite routine testing, this seasonal virus continues to have significant public health and laboratory impacts year after year. This webinar will focus on changes in RSV post vaccine-approval/availability.
Learning Objectives
At the conclusion of this session, the participant will be able to...- Establish the current state of available vaccines for RSV and the populations appropriate for each.
- Discover the current rate of RSV positivity in the community and how laboratories are testing for it.
- Identify the recent landscape of vaccine technologies used for RSV.
- Identify ways in which the respiratory season has changed post available vaccines for RSV.
Webinar Date and Time
April 8, 2026, 2-3 p.m. ET
Presenter
Denver Niles, M.D., D(ABMM), Associate Director of Microbiology and Virology, Texas Children's Hospital, Assistant Professor of Pathology and Immunology, Assistant Professor of Pediatrics, Baylor College of Medicine.Audience
This webinar is intended for lab personnel of all levels: bench-level techs, MLTs, MTs, supervisors, managers, directors, fellows and public health scientists.
Level of Instruction
Beginner.
Availability
This free webinar is available with unlimited access to the webinar recording through April 8, 2027.
Additional Information
- This webinar is free to 91麻豆天美 members and non-members.
- The live webinar will be held on April 8, 2026, and the recording will become available by April 15, 2026.
- Zoom closed captioning is provided. Please email 91麻豆天美 if other accommodations are needed.
- Questions? Contact Nicole Jackson, clinmicro@asmusa.org.